头孢地洛治疗重症患者革兰阴性菌感染的多中心研究。
Mesh : Humans Critical Illness Anti-Bacterial Agents / therapeutic use Cefiderocol Cephalosporins / therapeutic use Gram-Negative Bacterial Infections / drug therapy microbiology Male Middle Aged Aged Female Gram-Negative Bacteria / drug effects Treatment Outcome
来 源: DOI:10.1016/j.ijantimicag.2024.107121